Skip Navigation
Explore our COVID-19 Resources and Updates
CHS blue logo square
 
 
Home > Our Work > All Publications > 2003

Publications

Our publications keep professionals working across the public, private, and academic sectors informed on the most important developments and issues in health security and biosecurity.

Find an article or report by keywords:

 
 
Find an article or report or see all by area, author, or year:

Title:

Biodefense R&D: Anticipating Future Threats, Establishing a Strategic Environment

Authors:
Bradley T. Smith, Thomas V. Inglesby, Tara O'Toole
Date posted:
September 15, 2003
Publication type:
Article
Publication:

Biosecur Bioterror 2003;1(3):193-202

Publisher:
Mary Ann Liebert, Inc.
Availability:
Available on publisher's website
See also:

Full article as PDF

Introduction:

The ultimate objective of the U.S. Civilian Biodefense Strategy should be to eliminate the possibility of massively lethal bioterrorist attacks. A central pillar of this strategy must be an ambitious and aggressive scientific research, development, and production (R&D&P) program that delivers the diagnostic technologies, medicines, and vaccines needed to counter the range of bioweapons agents that might be used against the nation. A successful biodefense strategy must take account of the rapidly expanding spectrum of bioweapons agents and means of delivery made possible by 21st century advances in bioscientific knowledge and biotechnology. Meeting this challenge will require the engagement of America’s extraordinary scientific talent and investments of financial and political capital on a scale far beyond that now committed or contemplated. The purpose of this article is to provide a brief analysis of the current biomedical R&D&P environment and to offer recommendations for the establishment of a national biodefense strategy that could significantly diminish the suffering and loss that would accompany bioterrorist attacks. In the longer term, a robust biodefense R&D&P effort, if coupled to substantial improvements in medical and public health systems, could conceivably render biological weapons ineffective as agents of mass lethality.

 

 

Our Mission

To protect people’s health from epidemics and disasters and ensure that communities are resilient to major challenges.